-
Snibe received CE certificate (List A) for MAGLUMI HBsAg (CLIA) Assay
Snibe received the CE certificate (List A) for MAGLUMI® HBsAg (CLIA) assay On March 11, 2022. It further proves the high reliability of the quality and performance of Snibe products, as well as a verification of Snibe’s leading position in the field of chemiluminescence. -
Snibe SARS-COV-2 tests accurately detect Omicron variant
Based on assessment of sequences and bioinformatics analysis, we confirm that Snibe’s assays for detection of the SARS-CoV-2 virus in the table below are effective in detecting SARS-CoV-2 variants reported by WHO including B.1.1.529 (Omicron), B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), B.1.617.2 (Delta), C.37 (Lambda), B.1.617.1 (Kappa), etc. -
Snibe announced a global strategic cooperation with Thermo Fisher Scientific
From August 29th to 31st, 2019, the 15th National Congress of Laboratory Medicine (NCLM 2019), hosted by Chinese Medical Association and Chinese Society of Laboratory Medicine, was held at Suzhou International Expo Centre.
-
Snibe Shows Great Charms at EuroMedlab 2022 in Munich
EuroMedlab Munich 2022, the largest exhibition in the field of Clinical Chemistry and Laboratory Medicine in Europe, which attracted more than 2000 participants, was held in ICM International Congress Center from April 10 to 14, 2022.
-
Snibe Showcases Total Lab Automation at MEDLAB 2020
From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market. -
Snibe Shines at Medica 2019
Medica, known as the world's largest trade fair for medical technology, was held in Dusseldorf, Germany, from November 18th to 21st.
